Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
To assess the relative BA of a low-strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents after single dose administration and to assess BE of a regular strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents at steady state in men with prostate cancer
Janssen-Cilag International N.V.
Metastatic castration-resistant prostate cancer (mCRPC)
1 trial -
Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Istituto Gentili S.r.l.
Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.
1 trial -
[225Ac]Ac-AKY-2519 (therapeutic)
Aktis Oncology
Castration Resistant Metastatic Prostate Cancer
1 trial -
illuccix 68Ga-PSMA-11 Total Body PET-CT
Telix Innovations
Metastatic Castration-resistant Prostate Cancer
1 trial -
Anti-peristaltic ileosigmoid anastomosis
The First People's Hospital of Lianyungang
Constipation
1 trial -
COBICISTAT , OLAPARIB
Disc Medicine
Cancer
1 trial -
Carvedilol NORMON 6.25 mg tablets EFG., Il n'a pas de substance active. Le produit est un comprimé pelliculé sécable blanc, de forme ovale, de longueur 8mm, avec une gravure F57 sur une face et une barre de sécabilité sur l’autre face. Excipients: Prosolv Easytab SP (Cellulose microcristalline, Silice colloïdale, Sodium starch glycolate, Sodium stéaryl fumarate). Solution de pelliculage: (Hypromellose, PEG 3350, Candurin silver sheen)
Tour Hekla
Asymptomatic Child-Pugh A5 to B8 cirrhosis
1 trial -
Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets
Disc Medicine
chemotherapy-induced neuropathic pain
1 trial -
ENZALUTAMIDE, DOCETAXEL, ABIRATERONE
Fondazione Telethon ETS
metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown
1 trial -
FLUCORTAC 50 microgrammes, comprimé sécable, Cellulose microcristalline 50 microgrammes
H.A.C. Pharma
Neurogenic Orthostatic Hypotension
1 trial -
Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Allergic Rhinitis
1 trial -
Ketamine
Teva Pharma GmbH
Treatment Resistant Depression
1 trial -
Realgar-Indigo Naturalis Formulation Combined with Anlotinib
The First People's Hospital of Lianyungang
Platinum-resistant Ovarian Cancer (PROC)
1 trial -
Valproic acid
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial -
Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets
Bayer AG
metastatic castrate resistant prostate cancer (mCRPC)
1 trial -
lactulose (Kristalose®)
CUMBERLAND PHARMACEUTICALS INC
Constipation
1 trial -
Coffee
Hospital Authority, Hong Kong
Insulin Resistance
1 trial -
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
Fei Re Qing Granules
The First People's Hospital of Lianyungang
Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection
1 trial -
HCQ/CQ and CAB combined treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Resistance, Disease
1 trial -
Ketogenic diet
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial -
antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
carbohydrates
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Insulin Resistance
1 trial -
probiotic cocktail capsules
Hospital Authority, Hong Kong
Vancomycin-Resistant Enterococci
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources